Finance Watch: Did Mid-Summer Usher In A Mega-Round Comeback?

Hatteras Sees Value In Early Investments, Raises $200m Across Two Funds

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.